| Course | NR 506 Health Care Policy |
|---|---|
| Week | 3 |
| Paper type | Legislative process write-up |
| Length | About 1,150 words, 4 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | MSN |
| Updated | October 2026 |
Free sample paper for NR 506 Week 3
The Affordable Insulin Now Act, H.R. 6833, 117th Congress: Three Committees and No Hearing, a 232 to 193 House Vote, and a Bill Number That Became the September 2022 Continuing Resolution
Student Name
College of Nursing, Chamberlain University
NR 506: Health Care Policy
Instructor Name
Month Day, Year
The Affordable Insulin Now Act, H.R. 6833, 117th Congress: Three Committees and No Hearing, a 232 to 193 House Vote, and a Bill Number That Became the September 2022 Continuing Resolution
One Bill, One Session
This write-up follows one proposal through one Congress: H.R. 6833, the Affordable Insulin Now Act, introduced in the 117th Congress on February 25, 2022, by Representative Angie Craig of Minnesota's 2nd District, with 31 cosponsors. As introduced, it would have held private-plan cost-sharing for a month of selected insulin products to the smaller of $35 and one quarter of the plan's negotiated price, starting in 2023, and would have set a $35 limit on insulin cost-sharing in Medicare Part D (Affordable Insulin Now Act, 2022). The private insurance provision is the part my issue brief in Week 2 argued for.
The account below is drawn from the official record of actions on Congress.gov rather than from news coverage, because the record shows what happened to the text and coverage mostly shows what people said about it.
The Referral Decides a Lot
On the day it was introduced, the bill was referred to three House committees: Energy and Commerce, Ways and Means, and Education and Labor, each for the provisions within its jurisdiction. The triple referral follows the bill's content. Private group health plans are regulated under three parallel statutes, the Public Health Service Act, the Internal Revenue Code and ERISA, and each committee oversees one of them. Medicare Part D falls under both Energy and Commerce and Ways and Means. On February 28, Energy and Commerce referred the bill to its Subcommittee on Health.
A bill sent to three committees ordinarily faces three chances to be delayed or amended. What the record shows next is more telling: nothing. No committee held a hearing on H.R. 6833, and none marked it up or filed a report. The bill went to the House floor without passing through any of the committees it was referred to.
To the Floor by Rule
The route around the committees was a special rule. On March 31, 2022, the House adopted H. Res. 1017, reported by the Rules Committee, which provided for consideration of H.R. 6833 together with H.R. 3617, a cannabis bill, and allowed one hour of debate on the insulin bill. That is how a House majority moves a bill it wants voted on quickly: the Rules Committee sets the terms of debate, and the committees of jurisdiction are bypassed.
The minority's one procedural opportunity came at the end of debate. Representative Larry Bucshon of Indiana moved to recommit the bill to the Energy and Commerce Committee. The motion failed, 197 to 225. The House then passed H.R. 6833 by 232 to 193 (Roll no. 102).
Changes With Authors
The text the House passed was not the text introduced. According to the Congressional Research Service summaries of the two versions, the introduced bill set the Medicare Part D limit at $35 in 2023 regardless of whether a beneficiary had reached the out-of-pocket threshold, and at $35 from 2024 for those who had not. The passed version simply capped Medicare Part D cost-sharing for a month's supply of covered insulin at $35 beginning in 2023. The passed version also added two provisions not in the introduced bill: a further delay of a regulation on Part D manufacturer rebates, and an increase in funding for the Medicare Improvement Fund. The private insurance cap was unchanged.
Because there was no markup, these changes did not come from a committee vote. They were made in the text the House took up under the Rules Committee's rule. The added rebate-rule delay is worth noticing: it is a budget offset, a provision that saves federal money on paper, and its arrival between introduction and passage suggests the bill's managers were answering cost concerns before the floor vote.
The Senate, and a Different Bill Under the Same Number
The Senate received H.R. 6833 on April 4, 2022. It was read twice and placed on the Senate Legislative Calendar on May 24 and 25 as Calendar No. 389, without referral to a Senate committee. There it sat through the summer.
In August 2022, the Medicare part of the insulin proposal became law by another route. The Inflation Reduction Act, signed on August 16, 2022, included a $35 monthly limit on insulin cost-sharing in Medicare Part D and a parallel limit in Part B (Inflation Reduction Act, 2022). It did not include the private insurance cap.
Then, in late September, the Senate took up H.R. 6833 again, but not for insulin. On September 27, cloture on the motion to proceed was invoked, 72 to 23. On September 29, the Senate passed the bill, 72 to 25, with an amendment that replaced its content with a continuing resolution to fund the government, supplemental appropriations for Ukraine and the reauthorization of Food and Drug Administration user fees. On September 30, the House agreed to the Senate amendment, 230 to 201, and the President signed it the same day as Public Law 117-180, the Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 (Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2022).
The Record Over the Commentary
Commentary at the time described the Affordable Insulin Now Act in terms of who supported and opposed it. The record tells a more useful story for anyone trying to pass a similar bill. It shows that the proposal never had a hearing, so no committee record exists of testimony on how a private-plan cap would affect premiums or employers. It shows that the House vote was close to party lines, which predicts difficulty in a Senate that needs 60 votes for most legislation. And it shows that the only part of the proposal to become law did so in a budget reconciliation bill, which can pass the Senate with a simple majority but is limited to provisions with a direct budget effect.
Where It Actually Is Now
The honest answer to "what happened to the Affordable Insulin Now Act" has three parts. Its Medicare provision is law, through a different bill. Its private insurance provision died when the 117th Congress ended on January 3, 2023, having passed the House and never received a Senate vote. And its bill number is the public law that funded the government from October 2022, which means that a search for H.R. 6833 today returns a continuing resolution rather than an insulin bill. A proposal to cap insulin costs in private plans would have to be introduced again, with a new number, and would start from the beginning of the process.
References
Affordable Insulin Now Act, H.R. 6833, 117th Cong. (2022).
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023, Pub. L. No. 117-180, 136 Stat. 2114 (2022).
Inflation Reduction Act of 2022, Pub. L. No. 117-169, 136 Stat. 1818 (2022).
The Chamberlain NR 506 Week 3 instructions
The Week 3 write-up has you trace a health policy bill through the legislative process. Students are usually asked for the bill and session, its sponsor and purpose, committee referral and action, floor action, changes to the text, its current status and APA. Choose one bill in one session and identify it by number. Use the official record of actions as your main source. Explain why the bill went to the committees it did and what they did with it. Describe each floor step with its date and vote. Identify who changed the text and how. Say plainly where each part of the proposal ended up, even if by another route.
How this NR 506 Week 3 example is built
The opening introduces H.R. 6833, introduced on February 25, 2022, and explains using the record of actions. The referral section explains the three committees and notes that none held a hearing or markup. The floor section describes the Rules Committee's resolution, debate, the failed motion to recommit and the 232 to 193 passage. The text section uses the Congressional Research Service summaries to show changes between introduced and passed versions, made without a committee vote. The Senate section reports its placement on the calendar, the Medicare cap's enactment in the Inflation Reduction Act in August and the bill number's later use for continuing appropriations. The status section gives a three-part answer about what happened.
Where the points sit in the NR 506 Week 3 rubric
Legislative process rubrics in NR 506 generally reward accurate identification of the bill, correct description of each stage, use of primary sources, analysis of how the process shaped the outcome, a clear current status and APA. Following the record is the row this paper earns most, by dating each step from Congress.gov. Description of stages is credited for referral, rule, floor vote and Senate action. Analysis scores through the observation that the committees did nothing and the rule routed around them. Status earns points for a precise three-part answer. Text changes are credited because the paper says who made them. Three references, including two public laws, complete APA.
Common NR 506 Week 3 mistakes, and how to avoid them
Points vanish fastest when the write-up describes what a bill would do and never what happened to it. Another loss is relying on news coverage, which reports support and opposition but not process. Students also skip committee action, guess at dates or say a bill "died" without checking whether its text moved elsewhere. A bill that never went anywhere can still make a strong paper if the record shows why. State bills work if your legislature has an online record. Write about lobbying by describing positions on the record, not motives. Name the bill you are following, and an NR 506 legislative write-up can be traced through its record.
Get a NR 506 Week 3 example written to your instructions
Send the Week 3 instructions with any bill your section requires or approves, and a write-up following that proposal through its record comes back inside 24-48h, the first one free. If your classroom supplies a table or a milestone template, send it too and the chronology is written into its fields rather than beside them.
More NR 506 papers and MSN samples
- NR 506 Week 1: Health Policy at Work Discussion Post
- NR 506 Week 2: Insulin Cost Policy Issue Brief
- NR 506 Week 4: Policy Analysis Paper
- NR 506 Week 5: Rulemaking and Implementation Write-up
- NR 506 Week 6: Interest Group Analysis
- NR 506 Week 7: Policy Evaluation Write-up
- NR 506 Week 8: Policy Synthesis Paper
- NR 506NP Week 3: Opposing Argument Analysis
- NR 505 Week 3: Research Design Comparison Paper
- NR 508 Week 3: Drug Class Analysis
- NR 504 Week 3: Nurse Leadership Philosophy Statement
NR 506 Week 3 questions, answered
The bill I chose never went anywhere. Is that a problem?
It is usually a better assignment than one that passed. A proposal that died leaves a clear record of where it stopped and who let it stop, and accounting for that is exactly what the week is asking for. Bills that pass tend to carry long amendment histories that are harder to compress into the word count. Say plainly that it did not advance, then explain why.
Can I write about a state bill rather than a federal one?
In many sections yes, and state proposals are often easier to follow because the record is smaller and the committee structure simpler. Check your instructions first, since some ask specifically for federal legislation. If state work is allowed, pick a session that has closed, because a live proposal will change between drafting and submission and the write-up will read as stale.
How do I write about lobbying without accusing anyone?
Report what is filed and let the reader draw conclusions. Registered lobbying disclosures, witness lists and the organizations submitting written statements are all public, and describing them accurately requires no claim about motive. The sentence to avoid is the one asserting that a payment caused a vote, which the record almost never supports and which graders read as a lapse.
Where can I find a free NR 506 Week 3 sample paper?
The complete Week 3 history of H.R. 6833, with referral, the special rule, the vote, text changes, Senate action, the provisions enacted elsewhere and three references, can be read here.
What happened to the Medicare insulin provision in the NR 506 Week 3 paper?
It became law through a different bill, the Inflation Reduction Act signed in August 2022, while the private insurance cap never passed the Senate.